Washington | A minimally invasive technique can significantly reduce phantom limb pain – chronic pain emanating from the site of amputated limbs – that was previously untreatable, scientists have found.
A new study indicates that interventional radiologists applying cryoablation therapy, a targeted treatment using cold blasts, shows promise in improving the quality of life for patients suffering phantom limb pain. Until now, individuals with phantom limb pain have had few medical interventions available to them that resulted in significant reduction in their pain, said J David Prologo, assistant professor at the Emory University in US.
Now, with the promise of cryoablation, these individuals have a viable treatment option to target this lingering side effect of amputation – a condition that was previously largely untreatable, Prologo said. Military veterans wounded in combat and people with complex medical conditions, such as uncontrolled diabetes, constitute a significant part of the population affected by pain that seems to originate from the lost limb.
The interventional radiology team at Emory University treated 20 patients, with each person undergoing image-guided cryoablation of the nerve and scar tissue in the residual limb – the part of the body that remains after an amputation has been performed.
During cryoablation, a probe is precisely placed through the skin and the temperature is dropped for 25 minutes to create an ablation zone, shutting down nerve signals. Researchers asked patients to rate their pain on a visual analogue scale (VAS) that ranged from 1 (not painful) to 10 (extremely painful) before, seven days after and 45 days after the intervention.
Before cryoablation, patients reported an average pain score of 6.4 points. By day 45, the average score was 2.4 points. Many of the nerves contributing to these pains are inaccessible to physicians without image guidance, said Prologo. With the interventional radiologist skill set, we can solve tough problems through advanced image-guided therapies, and this promising treatment can target hard-to-find nerves and help amputees dramatically improve their lives – all in an outpatient setting, he said.